Free Account Opening + AMC Free Demat
Loading...

Bombay Super Hybrid Seeds IPO vs Indo US BioTech IPO

Comparision between Bombay Super Hybrid Seeds IPO and Indo US BioTech IPO.

IPO Details

Bombay Super Hybrid Seeds IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Indo US BioTech IPO is a SME Fixed Price Issue proposed to list at BSE SME.

  Bombay Super Hybrid Seeds IPO Indo US BioTech IPO
Logo Bombay Super Hybrid Seeds IPO Logo Indo US BioTech IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At NSE SME BSE SME
Lead Managers Monarch Networth Capital Ltd Swastika Investmart Ltd
Registrar Skyline Financial Services Private Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Bombay Super Hybrid Seeds IPO is up to ₹10.39 Cr whereas the issue size of the Indo US BioTech IPO is up to ₹7.29 Cr. The final issue price of Bombay Super Hybrid Seeds IPO is ₹60.00 per share and of Indo US BioTech IPO is ₹51.00 per share.

  Bombay Super Hybrid Seeds IPO Indo US BioTech IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹60.00 per share ₹51.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 2000 shares 2000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 17,32,000 shares 14,30,000 shares
Issue Size Total (Amount) up to ₹10.39 Cr up to ₹7.29 Cr

IPO Timetable

Bombay Super Hybrid Seeds IPO opens on Apr 12, 2018, while Indo US BioTech IPO opens on Apr 30, 2018. The closing date of Bombay Super Hybrid Seeds IPO and Indo US BioTech IPO is Apr 17, 2018, and May 03, 2018, respectively.

  Bombay Super Hybrid Seeds IPO Indo US BioTech IPO
Anchor Bid Date
Issue Open Apr 12, 2018 Apr 30, 2018
Issue Close Apr 17, 2018 May 03, 2018
Basis Of Allotment (Tentative) Apr 20, 2018
Initiation of Refunds (Tentative) Apr 23, 2018
Credit of Share (Tentative) Apr 24, 2018
Listing date (Tentative) Apr 25, 2018
Anchor Lockin End date 1 May 20, 2018
Anchor Lockin End date 2 Jul 19, 2018

Financials

Bombay Super Hybrid Seeds IPO P/E ratio is , as compared to Indo US BioTech IPO P/E ratio of .

  Bombay Super Hybrid Seeds IPO Indo US BioTech IPO
Financial
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 2,034.27 1,523.70 838.99 408.42 447.76
Total Revenue 10,970.05 6,313.27 3,132.65 3,012.50 1,571.16
Profit After Tax 80.48 27.43 3.74 24.80 27.26
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 1,293.66 1,368.76 767.52 605.19 626.38
Total Revenue 2,457.79 1,914.53 1,966.07 1,485.50 1,493.84
Profit After Tax 64.99 35.99 49.59 25.96 29.94
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Bombay Super Hybrid Seeds IPO retail investors (RII) are offered 8,22,000 shares while in Indo US BioTech IPO retail investors are offered 8,22,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Bombay Super Hybrid Seeds IPO and 0 shares in Indo US BioTech IPO.

  Bombay Super Hybrid Seeds IPO Indo US BioTech IPO
Anchor Investor Reserveration
Market Maker Reserveration 88,000 shares 74,000 shares
QIB 0 shares 0 shares
NII 8,22,000 shares 6,78,000 shares
RII 8,22,000 shares 6,78,000 shares
Employee
Others
Total 17,32,000 shares 14,30,000 shares

Bids Received (Subscription)

Bombay Super Hybrid Seeds IPO subscribed 9.67x in total, whereas Indo US BioTech IPO subscribed 19.74x.

  Bombay Super Hybrid Seeds IPO Indo US BioTech IPO
QIB (times)
NII (times) 4.56x 19.52x
Big NII (times)
Small NII (times)
RII (times) 14.45x 19.87x
Employee (times)
Other (times)
Total (times) 9.67x 19.74x

Comments

Add a public comment...